# Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

> **NCT00569985** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
- **DRUG:** carmustine
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **PROCEDURE:** autologous hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00569985
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2019-11-12
- **Final completion:** 2019-11-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569985, "Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00569985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*